Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

SYNTHON PHARMS INC

  • FDA Approval
  • Sept. 27, 2024, 08:36 UTC
  • 41
  • 0 comments

FDA approve GLATIRAMER ACETATE

Comment Full text

CIPLA

  • FDA Approval
  • Sept. 27, 2024, 08:36 UTC
  • 37
  • 0 comments

FDA approve NICARDIPINE HYDROCHLORIDE

Comment Full text

SYNTHON PHARMS INC

  • FDA Approval
  • Sept. 27, 2024, 08:36 UTC
  • 41
  • 0 comments

FDA approve GLATIRAMER ACETATE

Comment Full text

AMNEAL

  • FDA Approval
  • Sept. 27, 2024, 08:36 UTC
  • 45
  • 0 comments

FDA approve METHYLPREDNISOLONE

Comment Full text

APOTEX INC

  • FDA Approval
  • Sept. 27, 2024, 08:36 UTC
  • 42
  • 0 comments

FDA approve LEFLUNOMIDE

Comment Full text

TEVA

  • FDA Approval
  • Sept. 27, 2024, 08:36 UTC
  • 40
  • 0 comments

FDA approve DICLOFENAC POTASSIUM

Comment Full text

ZYDUS LIFESCIENCES

  • FDA Approval
  • Sept. 27, 2024, 08:36 UTC
  • 38
  • 0 comments

FDA approve LEFLUNOMIDE

Comment Full text

AUROBINDO PHARMA

  • FDA Approval
  • Sept. 27, 2024, 08:36 UTC
  • 37
  • 0 comments

FDA approve LEFLUNOMIDE

Comment Full text

ANNORA PHARMA

  • FDA Approval
  • Sept. 26, 2024, 17:47 UTC
  • 42
  • 0 comments

FDA approve FOSTAMATINIB

Comment Full text

ASTRAZENECA AB

  • FDA Approval
  • Sept. 26, 2024, 16:15 UTC
  • 42
  • 0 comments

FDA approve EPLONTERSEN SODIUM

Comment Full text
  • Previous
  • 296
  • 297
  • 298
  • 299
  • 300
  • Next

Search

News categories

  • Technical Exchange News(10602)
  • Event(2021)
  • SEC News(184969)
  • FDA Approval(9847)
  • Company Report(721)
  • Business News(122496)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin